New Test Predicts Alzheimer’s

Three markers in spinal fluid may help in development of treatment
By Marie Morris,  Newser Staff
Posted Aug 9, 2010 7:15 PM CDT
New Test Predicts Alzheimer’s
Jeannette Zeltzer, 81 and boyfriend Max Rakov, 92, who both have Alzheimer's disease, hold hands while sitting on a couch at their assisted living facility, March 8, 2008, in Newton, Mass.   (AP Photo/Greg M. Cooper)

The presence of certain biomarkers in spinal fluid can predict the development of Alzheimer's disease, even in patients who display no symptoms, according to breakthrough research being published tomorrow. "This is what everyone is looking for, the bull’s eye of perfect predictive accuracy," a doctor not connected with the study tells the New York Times. "This is literally on the cutting edge of where the field is."

The proteins A1-42, T-tau, and P-tau were present in the cerebrospinal fluid of 90% of Alzheimer's patients studied, as well as 72% of subjects with mild cognitive impairment and 36% of unimpaired subjects. That confirms the disease begins to develop before symptoms become apparent, the LA Times explains. For more on Alzheimer's and signs that Agatha Christie may have suffered from the disease, click here.

(Read more Alzheimer's disease stories.)

Get breaking news in your inbox.
What you need to know, as soon as we know it.
Sign up
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.